You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This issue of the Obstetrics and Gynecology Clinics provides an update in Gynecologic Oncology. Vulvar/Vaginal, cervical, uterine, and ovarian cancer are all covered, along with early detection and screening, and genetics and hereditary risk. There is also an article on trends in cancer care in North America, which discusses cancer care and cost and sustainability as well as practice evloution.
Collaborative care has been used successfully in obstetrics and gynecology for years. This issue reviews the basic collaborative model, that is collaboration among ob/gyns, midwives, and family physicians, and includes articles on successful birth center practice, secrets to a successful collaboration, and collaboration in today's environment. Dr. Waldman is past-President of ACOG, and his co-editor, Dr. Kennedy, is President of ACNM.
Biology of Female Cancers explores what can be learned about female cancers by summarizing what is known about the mechanisms of growth regulation and genetic features associated with common forms of female cancers, including malignancies of the breast, ovary, uterus, cervix, vulva, and gestational trophoblastic disease. The book describes the etiology, incidence, pathology, staging, and treatment of each type of cancer. The risk of developing particular tumor types and how their growth may be influenced by hormones, growth factors, and cytokines is also discussed. For oncologists, gynecologists and obstetricians, cell biologists, and everyone interested in learning more about female cancers, the Biology of Female Cancers offers a comprehensive, unique approach.
Human chorionic gonadotropin (hCG) is produced during pregnancy by the embryo. It promotes progesterone production by corpus luteal cells. It also functions in pregnancy to promote angiogenesis in uterine vasculature, it immuno-blands the invading placental tissue so it is not rejected by the maternal uterine tissues, promotes the growth of the uterus in line with the growth of the fetus, promotes the differentiation of growing cytotrophoblast cells, promotes the quiescence of contractions in the uterine myometrium during the course of pregnancy, and also has function in growth and development of fetal organs. The book describes the detailed biology, clinical chemistry, and clinical perspectives of hCG and associated molecules, and examines hCG, hyperglycosylated hCG and hCG free ß-subunit, 3 separate and independent molecules with totally sovereign physiological functions. It provides comprehensive information on hCG from basic science to clinical medicine Written by specialists in the field
In collaboration with Consulting Editor, Dr. William Rayburn, Dr. Paul Gluck has put together a state-of the-art issue of the Obstetrics and Gynecology Clinics of North America devoted to Patient Safety in Obstetrics and Gynecology. Clinical review articles from expert authors are specifically devoted to the following topics: The Patient Experience and Safety; The Certification Process Driving Patient Safety; Just Culture and Patient Safety; Patient’s Role in Patient Safety; Implementing Patient Safety Initiatives; Eliminating Disparities In Perinatal Care; Transparency and Disclosure; Leadership and Teams; Emerging Role of Drills and Simulations in Patient Safety; California Maternal Quality Care Collaborative: The Power of Collaboration; Role of the Patient Safety Organization in Advancing Patient Safety; Office of Patient Safety; Applying Patient Safety to Reduce Maternal Mortality; Benefits and Pitfalls of Ultrasound in Ob/Gyns; Obstetrical Anesthesia; Patient Safety in Outpatient Procedures; and Safety in Minimally Invasive Surgery. Readers will come away with the latest information they need to improve outcomes and safety in obstetric and gynecologic patients.
This issue of the Obstetrics and Gynecology Clinics covers the Medical and Surgical Management of Common Fertility Issues. Articles include Infertility Evaluation, Ovulation Induction, and problems such as fibroids, endometriosis, and ectopic pregnancy.
With collaboration of Dr. William Rayburn, Consulting Editor, Drs. Guille and Newman have created a state-of-the art issue that examines the mental health of pregnant women and those planning to become pregnant. Expert authors have contributed current clinical reviews on the following topics: Identification and treatment of peripartum anxiety disorders; Non-pharmacological treatments for peripartum depression; Management of opioid addiction in pregnancy (pro/cons of maintaining meds vs opioid withdrawal); Perinatal sleep problems: causes, complications and management; Impact of pregnancy loss on psychological functioning and grief outcomes; Eating disorders and body image disturbances among ...
Gynecologic oncology takes a fresh look at a critical aspect of cancer treatment planning. An international team of authors reviews the traditional prognostic and predictive factors such as tumor grade, histologic subtype, and grade and then goes a step further to review the growing number of molecular discoveries that have increasing clinical significance. The book is organized into comprehensive sections on ovarian, endometrial and cervical cancer and includes up to date reviews, newly discovered molecular pathways, genetic markers, molecular imaging techniques, and their relevance to clinical medicine. Prognostic and Predictive Factors in Gynecologic Oncology is illustrated with over 100 figures and is essential reading for oncologists, translational and basic scientists, as well as fellows, residents and students with a special interest in gynecologic oncology.
In consultation with Dr. William Rayburn, Dr. Muller has put together an issue designed to educate the reader on the rapid progress in Gynecologic Cancer Care. More than any other field in obstetrics and gynecology, gynecologic oncology has seen an explosion in integrated drug development and technology, including personalized medicine, germline and somatic testing, targeted therapeutics, biologic and immunotherapies, improved robotic technology, and a paradigm shift towards “less is more. Evolving data in quality measures including enhanced surgical recovery, integrative palliative care, and survivorship management has strengthened the need for a seemless team approach to the care of our ...